Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix in Benign Prostatic Hyperplasia
NCT00527488Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in benign prostatic hyperplasia (BPH), sponsored by Ferring Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
degarelix
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00527488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527488.